Arbutus Biopharma Corporation Common Stock
$4.250
USD
Last updated on --.
24h volume1.01M
24h highest4.3250 USD
24h lowest4.2500 USD
24h Price movement-0.93%
ABUS recent prices
24 Hours
-0.93%-$0.04
30 days
-1.01%-$0.044
60 days
-1.01%-$0.044
90 days
-1.24%-$0.054
Key data
Previous close4.2900 USD
Market cap839.54M USD
Volume1.01M
P/E ratio5.220000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.81000 USD
Net income (FY)160.72M USD
Revenue (FY)191.45M USD
Last report dateMay 13, 2026
About Arbutus Biopharma Corporation Common Stock
HeadquartersWARMINSTER
Employees (FY)19.00
Revenue per employee (FY)10.08M USD
Net income per employee (FY)8.46M USD
Listed onNasdaq
ABUS conversion tables
 |  |
|---|---|
| 0.5 ABUS | 2.125 USD |
| 1 ABUS | 4.250 USD |
| 5 ABUS | 21.25 USD |
| 10 ABUS | 42.5 USD |
| |
|---|---|
| 0.5 USD | 0.11765 ABUS |
| 1 USD | 0.23529 ABUS |
| 5 USD | 1.176 ABUS |
| 10 USD | 2.352 ABUS |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ABUS is trading at $4.250, -0.93% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ABUS stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ABUS is currently trading at $4.250, -0.93% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ABUS price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ABUS's P/E ratio is currently 5.220000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ABUS; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ABUS's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Arbutus Biopharma Corporation Common Stock's market cap is currently 839.54M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.01M
24h highest4.3250 USD
24h lowest4.2500 USD
24h Price movement-0.93%
Start trade with ABUS Perpetual
Sign up to trade